Chris Mason

Chris is a clinician-scientist with 30 years of cell and gene therapy experience spanning R&D, clinical medicine, and bioprocessing. He is a Founder of AVROBIO, OriBiotech and the Alliance of Regenerative Medicine [ARM].  He is on the Board of Directors of ARM, Krystal Biotech and OriBiotech; and is Full Professor of Cell and Gene Therapy at University College London.